What is the mechanism of action of cyclosporin (cyclosporine) in the treatment of lichen planus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Cyclosporin works in the treatment of lichen planus by suppressing the immune system, specifically targeting T-lymphocytes that are responsible for the inflammatory response in this condition, as supported by the British Association of Dermatologists guidelines 1.

Mechanism of Action

Cyclosporin inhibits calcineurin, an enzyme that activates T-cells, thereby reducing the production of inflammatory cytokines and interrupting the autoimmune process that causes lichen planus. This mechanism is crucial in reducing the symptoms of lichen planus, as noted in the guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 1.

Treatment and Dosage

For treatment, cyclosporin is typically prescribed at doses of 3-5 mg/kg/day, divided into two daily doses, as mentioned in the american society of hematology 2019 guidelines 1. It can be used topically as a 0.1% mouth rinse for oral lichen planus, or systemically for severe or widespread disease. Treatment duration usually ranges from 8-12 weeks, with regular monitoring of blood pressure, kidney function, and drug levels required due to potential side effects.

Side Effects and Precautions

Patients should be aware that cyclosporin can cause hypertension, nephrotoxicity, increased risk of infections, and hirsutism, as highlighted in the british association of dermatologists guidelines 1. It's generally reserved for severe, recalcitrant cases of lichen planus that haven't responded to first-line treatments like corticosteroids. Patients taking cyclosporin should avoid grapefruit juice and certain medications that may interact with it, and should have baseline laboratory tests before starting treatment, as advised in the guidelines 1.

Key Considerations

  • Regular monitoring of blood pressure, kidney function, and drug levels is required due to potential side effects.
  • Patients should be aware of the potential side effects and precautions, including hypertension, nephrotoxicity, and increased risk of infections.
  • Cyclosporin is generally reserved for severe, recalcitrant cases of lichen planus that haven't responded to first-line treatments.
  • Baseline laboratory tests are necessary before starting treatment, and patients should avoid grapefruit juice and certain medications that may interact with cyclosporin.

From the FDA Drug Label

Cyclosporine is a potent immunosuppressive agent that in animals prolongs survival of allogeneic transplants involving skin, kidney, liver, heart, pancreas, bone marrow, small intestine, and lung The effectiveness of cyclosporine results from specific and reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited. Cyclosporine also inhibits lymphokine production and release including interleukin-2

The mechanism of action of cyclosporin in the treatment of lichen planus is likely due to its immunosuppressive effects, specifically the inhibition of T-lymphocytes and the reduction of lymphokine production, including interleukin-2. This suggests that cyclosporin may work by suppressing the immune response that contributes to the development of lichen planus. 2

From the Research

Mechanism of Action of Cyclosporin in Lichen Planus

  • Cyclosporin is an immunosuppressive medication that works by inhibiting the activity of T-lymphocytes, which are a type of white blood cell involved in the immune response 3, 4.
  • In the context of lichen planus, cyclosporin is thought to reduce the inflammation and immune-mediated damage that characterizes the disease 5, 6.

Efficacy of Cyclosporin in Lichen Planus

  • Studies have shown that cyclosporin can be effective in treating lichen planus, particularly in cases that are resistant to other treatments 3, 4.
  • A short course of oral cyclosporin has been shown to alleviate symptoms, resolve clinical activity, and halt the progression of hair loss in patients with lichen planopilaris, a variant of lichen planus that affects the scalp 5.
  • Cyclosporin has also been compared to other immunosuppressive medications, such as methotrexate, and has been found to have similar efficacy in treating refractory lichen planopilaris 6.

Comparison with Other Treatments

  • Cyclosporin is one of several immunosuppressive medications that can be used to treat lichen planus, including methotrexate, azathioprine, and mycophenolate mofetil 3, 4.
  • The choice of medication depends on the severity and extent of the disease, as well as the patient's overall health and medical history 4.
  • Cyclosporin may be considered a second-line treatment for lichen planus, to be used when first-line treatments such as topical corticosteroids and phototherapy are not effective 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of cutaneous lichen planus (part 2): a review of systemic therapies.

The Journal of dermatological treatment, 2019

Research

Individualizing treatment and choice of medication in lichen planus: a step by step approach.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2013

Research

Short course of oral cyclosporine in lichen planopilaris.

Journal of the American Academy of Dermatology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.